A carregar...
Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis
BACKGROUND: Parenterally administered ascorbic acid modulates sepsis-induced inflammation and coagulation in experimental animal models. The objective of this randomized, double-blind, placebo-controlled, phase I trial was to determine the safety of intravenously infused ascorbic acid in patients wi...
Na minha lista:
Main Authors: | , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
BioMed Central
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3937164/ https://ncbi.nlm.nih.gov/pubmed/24484547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-12-32 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|